<DOC>
	<DOCNO>NCT02405923</DOCNO>
	<brief_summary>This multicenter , control , randomize , prospective , non-inferiority , double blind intervention trial evaluate child growth ( 6 , 9 12 month ) use rice hydrolyse protein formula compare extensively cow 's milk protein hydrolyse formula management Cow 's Milk Protein Allergy ( CMPA ) .</brief_summary>
	<brief_title>Growth , Safety Tolerance Rice Protein Hydrolysate Formula Infants With Cow 's Milk Protein Allergy</brief_title>
	<detailed_description>The main purpose study demonstrate rice protein hydrolyse base formula manufacture Ordesa ensure proper growth secondary outcome , formula devoid risk arsenic potential contaminant toxicity effect duration CMA ( Cow Milk Allergy ) cow 's milk protein allergy .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Milk Hypersensitivity</mesh_term>
	<criteria>Subjects 10 month old clinical history reaction cow 's milk protein and/or confirm diagnosis ( grade II anaphylaxis ) allergy cow 's milk protein one follow criterion , within two month prior baseline visit eligible enter study : Negative positive skin prick test ( fresh milk , rice , casein hydrolysate ) Negative positive specific IgE cow 's milk protein ( alphalactalbumine , betalactoglobuline , caseine cow 's milk ) Negative positive Milk Atopy Patch Test Positive Double Blind Placebo Control Food Challenge ( DBPCFC ) cow milk Gestational Age 3742 week inclusive Apgar SCORE &gt; 7 5 minute Singleton birth Birth weight â‰¥2.500 g Written inform consent Previous sign allergy extensively hydrolyse formula Confirmed history acute severe , potentially life threaten reaction isolate accidental ingestion cow 's milk e.g . history anaphylactic reaction , grade equal grade III , could compatible allocation eHF group Daily formula intake &lt; 100 ml Major congenital malformation neonatal disease Severe concurrent chronic disease Intrauterine growth retardation Neonatal infection ( e.g . CMV , HIV ) Simultaneous participation clinical trial Parents sign write informed consent Unable adhere protocol requirement study visit due non compliance parent caregiver . Liver , kidney , haematological abnormality judge clinically investigator baseline .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>10 Months</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>